デフォルト表紙
市場調査レポート
商品コード
1014704

細胞および遺伝子療法の世界市場 - 2030年までの機会と戦略:COVID-19の影響と変化

Cell and Gene Therapy market Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

出版日: | 発行: The Business Research Company | ページ情報: 英文 282 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.57円
細胞および遺伝子療法の世界市場 - 2030年までの機会と戦略:COVID-19の影響と変化
出版日: 2021年06月16日
発行: The Business Research Company
ページ情報: 英文 282 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の細胞および遺伝子療法市場について調査しており、市場規模や予測、成長および抑制要因、COVID-19による影響、競合情勢、市場シェア、市場の動向と戦略、製品・用途・地域/国別の市場分析、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 細胞および遺伝子療法市場のエグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

  • 地域別セグメンテーション
  • 製品別セグメンテーション
  • 用途別セグメンテーション

第7章 細胞および遺伝子療法市場の特徴

  • 製品別のセグメンテーション
    • 細胞療法
    • 遺伝子療法
  • 用途別セグメンテーション
    • 腫瘍
    • 神経障害
    • その他

第8章 細胞および遺伝子療法の市場動向と戦略

  • キメラ抗原受容体(CAR)T細胞療法
  • 世界の研究イニシアチブと資金提供
  • 細胞および遺伝子療法における先進技術の統合
  • 遺伝子編集への注目の高まり
  • 細胞および遺伝子療法を促進するための提携と買収の増加
  • パイプライン研究と医薬品開発の数の増加
  • 投資の拡大と製造施設の拡張

第9章 細胞および遺伝子療法市場に対するCOVID-19の影響

  • イントロダクション
  • 製造および商業活動への影響
  • COVID-19治療への影響
  • 薬物療法
  • 結論

第10章 世界の細胞および遺伝子療法の市場規模と成長

  • 市場規模
  • 市場成長(2015-2020)売上
    • 市場の成長要因(2015-2020)
    • 市場の抑制要因(2015-2020)
  • 市場成長予測(2020-2025、2030F)売上
    • 市場の成長要因(2020-2025)
    • 市場の抑制要因(2020-2025)

第11章 世界の細胞および遺伝子療法市場のセグメンテーション

  • 世界の細胞および遺伝子療法市場、製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
    • 遺伝子療法
    • 細胞療法
  • 世界の細胞および遺伝子療法市場、用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
    • 腫瘍
    • 神経障害
    • その他

第12章 細胞および遺伝子療法市場、地域および国別分析

  • 世界の細胞および遺伝子療法市場、地域別、実績および予測(2015-2020、2025F、2030F)売上
  • 世界の細胞および遺伝子療法市場、国別、実績および予測(2015-2020、2025F、2030F)売上

第13章 アジア太平洋地域の細胞および遺伝子療法市場

  • アジア太平洋の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 国別分析
  • 中国の細胞および遺伝子療法市場
  • 中国の細胞および遺伝子療法市場概要
    • 国情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 中国:市場成長(2015-2020)売上
  • 中国:市場成長予測(2020-2025、2030F)売上
  • 中国:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 中国:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • インドの細胞および遺伝子療法市場
  • インドの細胞および遺伝子療法市場概要
    • 国情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 減税
    • 法人税構造
    • 投資
    • 大手企業
  • インド:市場成長(2015-2020)売上
  • インド:市場成長予測(2020-2025、2030F)売上
  • インド:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • インド:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 日本の細胞および遺伝子療法市場
  • 日本の細胞および遺伝子療法市場概要
    • 国情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 減税
    • 法人税構造
    • 投資
    • 大手企業
  • 日本:市場成長(2015-2020)売上
  • 日本:市場成長予測(2020-2025、2030F)売上
  • 日本:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 日本:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • オーストラリアの細胞および遺伝子療法市場
  • オーストラリア:市場成長(2015-2020)売上
  • オーストラリア:市場成長予測(2020-2025、2030F)売上
  • オーストラリア:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • オーストラリア:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • インドネシアの細胞および遺伝子療法市場
  • インドネシア:市場成長予測(2020-2025、2030F)売上
  • インドネシア:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • インドネシア:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 韓国の細胞および遺伝子療法市場
  • 韓国:市場成長(2015-2020)売上
  • 韓国:市場成長予測(2020-2025、2030F)売上
  • 韓国:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 韓国:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第14章 西欧の細胞および遺伝子療法市場

  • 西欧の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 国別分析
  • 英国の細胞および遺伝子療法市場
  • 英国の細胞および遺伝子療法市場概要
    • 国情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 英国:市場成長(2015-2020)売上
  • 英国:市場成長予測(2020-2025、2030F)売上
  • 英国:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 英国:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • ドイツの細胞および遺伝子療法市場
  • ドイツ:市場成長(2015-2020)売上
  • ドイツ:市場成長予測(2020-2025、2030F)売上
  • ドイツ:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • ドイツ:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • フランスの細胞および遺伝子療法市場
  • フランス:市場成長(2015-2020)売上
  • フランス:市場成長予測(2020-2025、2030F)売上
  • フランス:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • フランス:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第15章 東欧の細胞および遺伝子療法市場

  • 東欧の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 国別分析
  • ロシアの細胞および遺伝子療法市場
  • ロシア:市場成長(2015-2020)売上
  • ロシア:市場成長予測(2020-2025、2030F)売上
  • ロシア:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • ロシア:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第16章 北米の細胞および遺伝子療法市場

  • 北米の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 国別分析
  • 米国の細胞および遺伝子療法市場
  • 米国の細胞および遺伝子療法市場概要
    • 国情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 米国:市場成長(2015-2020)売上
  • 米国:市場成長予測(2020-2025、2030F)売上
  • 米国:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 米国:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第17章 南米の細胞および遺伝子療法市場

  • 南米の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 徴収された税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 国別分析
  • ブラジルの細胞および遺伝子療法市場
  • ブラジル:市場成長(2015-2020)売上
  • ブラジル:市場成長予測(2020-2025、2030F)売上
  • ブラジル:製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • ブラジル:用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第18章 中東の細胞および遺伝子療法市場

  • 中東の細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 市場情報
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 主要な協会
    • 課税される税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長(2015-2020)売上
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第19章 アフリカの細胞および遺伝子療法市場

  • アフリカの細胞および遺伝子療法市場概要
    • 地域情報
    • COVID-19の影響
    • 背景情報
    • 政府のイニシアチブ
    • 規則
    • 規制機関
    • 協会
    • 課税される税金
    • 法人税構造
    • 投資
    • 大手企業
  • 市場成長予測(2020-2025、2030F)売上
  • 製品別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上
  • 用途別セグメンテーション、実績および予測(2015-2020、2025F、2030F)売上

第20章 世界の細胞および遺伝子療法市場の競合情勢

  • 企業プロファイル
  • Biogen Inc.
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Novartis AG
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Gilead Sciences, Inc.
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Ionis Pharmaceuticals, Inc.
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Alnylam Pharmaceuticals, Inc.
    • 企業概要
    • 製品・サービス
    • 事業戦略
    • 財務概要

第21章 細胞および遺伝子療法市場における主要な合併と買収

  • Thermo Fisher ScientificがNovasepからウイルスベクター事業を8億7,576万米ドルで買収
  • AstellasがAudentesTherapeuticsを30億米ドルで買収
  • RocheがSparkTherapeuticsIncorporatedを48億米ドルで買収
  • VertexがSemmaTherapeuticsを9億5,000万米ドルで買収
  • BayerがBlueRockTherapeuticsを10億米ドルで買収
  • Biogenが8億米ドルでNightstarTherapeuticsを買収
  • Catalentが12億米ドルでParagonBioservicesIncorporatedを買収
  • NovartisがAveXisを87億米ドルで買収

第22章 細胞および遺伝子療法市場の機会と戦略

  • 2025年の世界の細胞および遺伝子療法市場-最も新しい機会を提供する国
  • 2025年の世界の細胞および遺伝子療法市場-最も新しい機会を提供するセグメント
  • 2025年の世界の細胞および遺伝子療法市場-成長戦略
    • 市場動向ベースの戦略
    • 競合の戦略

第23章 細胞および遺伝子療法市場、結論・提言

  • 結論
  • 提言

第24章 付録

目次
Product Code: o&s245

Cell and Gene Therapy Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cell and gene therapy market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cell and gene therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cell and gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cell and gene therapy market, and compares it with other markets.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type and by interest rate.

Market Characteristics - The market characteristics section of the report defines and explains the cell and gene therapy market. This chapter also defines and describes goods and related services covered in the report.

Supply Chain - The supply chain section of the report defines and explains the key players in the cell and gene therapy industry supply chain.

Product/Service Analysis - The product/service analysis section of the report describes the leading products/services in the cell and gene therapy market along with key features and differentiators for those products/services.

Customer Information - This chapter covers recent customers' trends/preferences in the global cell and gene therapy market.

Trends And Strategies - This chapter describes the major trends shaping the global cell and gene therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of CoVID-19 - This section describes the impact of COVID-19 on the cell and gene therapy market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2015-2030) and analysis for different segments.

Global Macro Comparison - The global cell and gene therapy market comparison with macro-economic factors gives the cell and gene therapy market size, percentage of GDP, and average cell and gene therapy market expenditure.

Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global cell and gene therapy market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Background - This section describes the cell and gene therapy market. This chapter includes the global cell and gene therapy market 2015-19 and 2019-23 values, and regional analyses for the cell and gene therapy market.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for cell and gene therapy companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Product: Cell Therapy; Gene Therapy

2) By Application: Oncology; Neurological Disorders; Others

Companies Mentioned: Biogen Inc.; Novartis AG; Gilead Sciences; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals Inc.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: USA; China; Japan; Germany; France; UK; Russia; India; Brazil; Australia; South Korea; Indonesia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cell and gene therapy indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Cell And Gene Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Product
  • 6.3. Segmentation By Application

7. Cell And Gene Therapy Market Characteristics

  • 7.1. Segmentation By Product
    • 7.1.1.Cell Therapy
    • 7.1.2.Gene Therapy
  • 7.2. Segmentation By Application
    • 7.2.1.Oncology
    • 7.2.2.Neurological Disorders
    • 7.2.3.Others

8. Cell And Gene Therapy Market Trends And Strategies

  • 8.1. Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • 8.2. Global Research Initiatives And Funding
  • 8.3. Integration Of Advanced Technologies In Cell And Gene Therapies
  • 8.4. Rising Focus On Gene Editing
  • 8.5. Increasing Partnerships And Acquisitions For Promoting Cell And Gene Therapies
  • 8.6. Increasing Number Of Pipeline Studies And Drug Development
  • 8.7. Growing Investments and Manufacturing Facility Expansion

9. Impact Of COVID-19 On The Cell And Gene Therapy Market

  • 9.1. Introduction
  • 9.2. Impact On Manufacturing And Commercial Operations
  • 9.3. COVID-19 Impact On Treatment
  • 9.4. Drug Therapies
  • 9.5. Conclusion

10. Global Cell And Gene Therapy Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2020
    • 10.2.2. Restraints On The Market 2015 - 2020
  • 10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 10.3.1. Drivers Of The Market 2020 - 2025
    • 10.3.2. Restraints On The Market 2020 - 2025

11. Global Cell And Gene Therapy Market Segmentation

  • 11.1. Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Gene Therapy
    • 11.1.2. Cell Therapy
  • 11.2. Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Oncology
    • 11.2.2. Neurological Disorders
    • 11.2.3. Others

12. Cell And Gene Therapy Market, Regional And Country Analysis

  • 12.1. Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Cell And Gene Therapy Market

  • 13.1. Asia-Pacific Cell And Gene Therapy Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.3. Asia-Pacific Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.4. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.6. Asia-Pacific Cell And Gene Therapy Market: Country Analysis
  • 13.7. China Cell And Gene Therapy Market
  • 13.8. China Cell And Gene Therapy Market Overview
    • 13.8.1. Country Information
    • 13.8.2. Impact of COVID-19
    • 13.8.3. Market Information
    • 13.8.4. Background Information
    • 13.8.5. Government Initiatives
    • 13.8.6. Regulations
    • 13.8.7. Regulatory Bodies
    • 13.8.8. Major Associations
    • 13.8.9. Taxes Levied
    • 13.8.10. Corporate Tax Structure
    • 13.8.11. Investments
    • 13.8.12. Major Companies
  • 13.9. China Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.10. China Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.11. China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.12. China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.13. India Cell And Gene Therapy Market
  • 13.14. India Cell And Gene Therapy Market Overview
    • 13.14.1. Country Information
    • 13.14.2. Impact of COVID-19
    • 13.14.3. Market Information
    • 13.14.4. Background Information
    • 13.14.5. Government Initiatives
    • 13.14.6. Regulations
    • 13.14.7. Regulatory Bodies
    • 13.14.8. Major Associations
    • 13.14.9. Tax Levied
    • 13.14.10. Corporate Tax Structure
    • 13.14.11. Investments
    • 13.14.12. Major Companies
  • 13.15. India Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.16. India Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.17. India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.18. India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.19. Japan Cell And Gene Therapy Market
  • 13.20. Japan Cell And Gene Therapy Market Overview
    • 13.20.1. Country Information
    • 13.20.2. Impact of COVID-19
    • 13.20.3. Market Information
    • 13.20.4. Background Information
    • 13.20.5. Government Initiatives
    • 13.20.6. Regulations
    • 13.20.7. Regulatory Bodies
    • 13.20.8. Major Associations
    • 13.20.9. Tax Levied
    • 13.20.10. Corporate Tax Structure
    • 13.20.11. Investments
    • 13.20.12. Major Companies
  • 13.21. Japan Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.22. Japan Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.23. Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.24. Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.25. Australia Cell And Gene Therapy Market
  • 13.26. Australia Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.27. Australia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.28. Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.29. Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.30. Indonesia Cell And Gene Therapy Market
  • 13.31. Indonesia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.32. Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.33. Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.34. South Korea Cell And Gene Therapy Market
  • 13.35. South Korea Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.36. South Korea Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.37. South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.38. South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Cell And Gene Therapy Market

  • 14.1. Western Europe Cell And Gene Therapy Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.3. Western Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.4. Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.6. Western Europe Cell And Gene Therapy Market: Country Analysis
  • 14.7. UK Cell And Gene Therapy Market
  • 14.8. UK Cell And Gene Therapy Market Overview
    • 14.8.1. Country Information
    • 14.8.2. Impact Of COVID-19
    • 14.8.3. Market Information
    • 14.8.4. Background Information
    • 14.8.5. Government Initiatives
    • 14.8.6. Regulations
    • 14.8.7. Regulatory Bodies
    • 14.8.8. Major Associations
    • 14.8.9. Taxes Levied
    • 14.8.10. Corporate Tax Structure
    • 14.8.11. Investments
    • 14.8.12. Major Companies
  • 14.9. UK Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.10. UK Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.11. UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.12. UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.13. Germany Cell And Gene Therapy Market
  • 14.14. Germany Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.15. Germany Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.16. Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.17. Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.18. France Cell And Gene Therapy Market
  • 14.19. France Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.20. France Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.21. France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.22. France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Cell And Gene Therapy Market

  • 15.1. Eastern Europe Cell And Gene Therapy Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.3. Eastern Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.4. Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.6. Eastern Europe Cell And Gene Therapy Market: Country Analysis
  • 15.7. Russia Cell And Gene Therapy Market
  • 15.8. Russia Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.9. Russia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.10. Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.11. Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Cell And Gene Therapy Market

  • 16.1. North America Cell And Gene Therapy Market Overview
    • 16.1.1. Region Information
    • 16.1.2. COVID-19 Impact
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Regulations
    • 16.1.6. Regulatory Bodies
    • 16.1.7. Major Associations
    • 16.1.8. Taxes Levied
    • 16.1.9. Corporate Tax Structure
    • 16.1.10. Investments
    • 16.1.11. Major Companies
  • 16.2. North America Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.3. North America Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.4. North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.6. North America Cell And Gene Therapy Market: Country Analysis
  • 16.7. USA Cell And Gene Therapy Market
  • 16.8. USA Cell And Gene Therapy Market Overview
    • 16.8.1. Country Information
    • 16.8.2. COVID-19 Impact
    • 16.8.3. Market Information
    • 16.8.4. Background Information
    • 16.8.5. Government Initiatives
    • 16.8.6. Regulations
    • 16.8.7. Regulatory Bodies
    • 16.8.8. Major Associations
    • 16.8.9. Taxes Levied
    • 16.8.10. Corporate Tax Structure
    • 16.8.11. Investments
    • 16.8.12. Major Companies
  • 16.9. USA Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.10. USA Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.11. USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.12. USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Cell And Gene Therapy Market

  • 17.1. South America Cell And Gene Therapy Market Overview
    • 17.1.1. Region Information
    • 17.1.2. COVID-19 Impact
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. South America Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.4. South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.6. South America Cell And Gene Therapy Market: Country Analysis
  • 17.7. Brazil Cell And Gene Therapy Market
  • 17.8. Brazil Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.9. Brazil Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.10. Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.11. Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Cell And Gene Therapy Market

  • 18.1. Middle East Cell And Gene Therapy Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID-19 Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Middle East Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.4. Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.5. Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Cell And Gene Therapy Market

  • 19.1. Africa Cell And Gene Therapy Market Overview
    • 19.1.1. Regional Information
    • 19.1.2. COVID-19 Impact
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Associations
    • 19.1.8. Taxes levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Africa Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.3. Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.4. Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Cell And Gene Therapy Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Biogen Inc.
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Novartis AG
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Gilead Sciences, Inc.
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Ionis Pharmaceuticals, Inc.
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Alnylam Pharmaceuticals, Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market

  • 21.1. Thermo Fisher Scientific Acquired Viral Vector Business From Novasep for $875.76 million
  • 21.2. Astellas Acquired Audentes Therapeutics for $3 billion
  • 21.3. Roche Acquired Spark Therapeutics Incorporated for $4.8 billion
  • 21.4. Vertex Acquired Semma Therapeutics for $950 million
  • 21.5. Bayer Acquired BlueRock Therapeutics for $1 billion
  • 21.6. Biogen Acquired Nightstar Therapeutics for $800 million
  • 21.7. Catalent Acquired Paragon Bioservices Incorporated for $1.2 billion
  • 21.8. Novartis Acquired AveXis for $8.7 billion

22. Cell And Gene Therapy Market Opportunities And Strategies

  • 22.1. Global Cell And Gene Therapy Market In 2025 - Countries Offering Most New Opportunities
  • 22.2. Global Cell And Gene Therapy Market In 2025 - Segments Offering Most New Opportunities
  • 22.3. Global Cell And Gene Therapy Market In 2025 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Cell And Gene Therapy Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Price
    • 23.2.3. Place
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer